343 results on '"Umene-Nakano, Wakako"'
Search Results
2. Relationship between the catechol-O-methyl transferase Val108/158Met genotype and brain volume in treatment-naive major depressive disorder: Voxel-based morphometry analysis
3. Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: A VBM analysis of brain MRI
4. Current smoking rate in patients with psychiatric disorders in Japan: Questionnaire survey
5. Relationship between white matter integrity and serum cortisol levels in drug-naive patients with major depressive disorder: diffusion tensor imaging study using tract-based spatial statistics
6. Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder
7. Plasma Levels of Metabolites of Catecholamine in Nicotine-Dependent Patients Treated With Varenicline
8. The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients
9. Introducing the concept of modern depression in Japan; an international case vignette survey
10. Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population
11. Relationships between stress, social adaptation, personality traits, brain-derived neurotrophic factor and 3-methoxy-4-hydroxyphenylglycol plasma concentrations in employees at a publishing company in Japan
12. The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients
13. Critical examination of a correlation between brain gamma-aminobutyric acid (GABA) concentrations and a personality trait of extroversion in healthy volunteers as measured by a 3 Tesla proton magnetic resonance spectroscopy study
14. SIRT1 gene is associated with major depressive disorder in the Japanese population
15. The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder
16. Does the ‘hikikomori’ syndrome of social withdrawal exist outside Japan? A preliminary international investigation
17. Lack of Association Between MAGEL2 and Schizophrenia and Mood Disorders in the Japanese Population
18. Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder
19. Plasma catecholamine metabolite levels and the activities of psychiatric symptoms in systemic lupus erythematosus
20. Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients
21. Reliability, validity and clinical utility of a Japanese version of the Social Adaptation Self–evaluation Scale as calibrated using the Beck Depression Inventory
22. Three polymorphisms of the eNOS gene and plasma levels of metabolites of nitric oxide in depressed Japanese patients: a preliminary report
23. No association between BDNF Val66Met polymorphism and emergence of psychiatric symptoms in systemic lupus erythematosus patients
24. A case of schizophrenia with Meige syndrome induced by long-term aripiprazole successfully treated with perospirone
25. Plasma levels of brain – derived neurotrophic factor and interleukin – 6 in patients with dysthymic disorder: comparison with age – and sex – matched major depressed patients and healthy controls
26. Impact of biopsychosocial factors on psychiatric training in Japan and overseas: Are psychiatrists oriented to mind, brain, or sociocultural issues?
27. Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population
28. No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations
29. No support for replication of the genetic variants identified by a recent mega-analysis of the treatment response to antidepressants
30. Varenicline does not increase serum BDNF levels in patients with nicotine dependence
31. Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study
32. Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression
33. Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia
34. Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: Comparison between milnacipran and paroxetine
35. Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients
36. Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence
37. Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression
38. Addition of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline
39. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: A pilot study
40. Acute risperidone treatment did not increase daily cigarette consumption or plasma levels of cotinine and caffeine: a pilot study
41. Hikikomori as a possible clinical term in psychiatry: a questionnaire survey
42. Steroid psychosis in a polyarteritis nodosa patient successfully treated with risperidone: tracking serum brain-derived neurotrophic factor levels longitudinally
43. Development and validation of the 22‐item Tarumi's Modern‐Type Depression Trait Scale: Avoidance of Social Roles, Complaint, and Low Self‐Esteem (TACS‐22)
44. Tarumi’s Modern-Type Depression Trait Scale: Avoidance of Social Roles, Complaint, and Low Self-Esteem--22 Item Version
45. Development and validation of the 25‐item Hikikomori Questionnaire (HQ‐25)
46. 25-item Hikikomori Questionnaire
47. Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism
48. Suicidal ideation and burnout among psychiatric trainees in Japan
49. No significant association between brain-derived neurotrophic factor gene rs6265 and cognitive function in Japanese patients with schizophrenia
50. Genetic Variation in the Catechol-O-Methyl Transferase Val108/158Met Is Linked to the Caudate and Posterior Cingulate Cortex Volume in Healthy Subjects: Voxel-Based Morphometry Analysis of Brain Magnetic Resonance Imaging
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.